Science Applications Intl Corp Financials
Science Applications Intl Corp (SAIC) reported $7.3B in revenue for fiscal year 2026, down 2.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash generation, not sales growth, funds large buybacks while the balance sheet trades improved liquidity for higher leverage.
In FY2026, operating cash flow of$609M exceeded net income of$358M , indicating cash conversion was stronger than earnings alone imply. The rise in free-cash-flow margin from6.1% to8.0% across FY2025–FY2026 reinforces that cash availability improved even as sales softened.
Current ratio recovered to 1.2x from 0.8x in FY2026, easing near-term coverage pressure. Meanwhile, debt-to-equity rose to 1.6x from 1.2x, so liquidity repair did not mean lower overall leverage.
The company repurchased
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Science Applications Intl Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Science Applications Intl Corp has an operating margin of 7.2%, meaning the company retains $7 of operating profit per $100 of revenue. This strong profitability earns a score of 72/100, reflecting efficient cost management and pricing power. This is down from 7.5% the prior year.
Science Applications Intl Corp's revenue declined 2.9% year-over-year, from $7.5B to $7.3B. This contraction results in a growth score of 28/100.
Science Applications Intl Corp has elevated debt relative to equity (D/E of 1.65), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 14/100, reflecting increased financial risk.
Science Applications Intl Corp's current ratio of 1.20 is below the typical benchmark, resulting in a score of 28/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Science Applications Intl Corp has a free cash flow margin of 8.0%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.
Science Applications Intl Corp earns a strong 23.9% return on equity (ROE), meaning it generates $24 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 80/100. This is up from 22.9% the prior year.
Science Applications Intl Corp scores 2.95, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Science Applications Intl Corp passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Science Applications Intl Corp generates $1.70 in operating cash flow ($609.0M OCF vs $358.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Science Applications Intl Corp earns $4.07 in operating income for every $1 of interest expense ($521.0M vs $128.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Science Applications Intl Corp generated $7.3B in revenue in fiscal year 2026. This represents a decrease of 2.9% from the prior year.
Science Applications Intl Corp's EBITDA was $551.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6.3% from the prior year.
Science Applications Intl Corp reported $358.0M in net income in fiscal year 2026. This represents a decrease of 1.1% from the prior year.
Science Applications Intl Corp earned $7.70 per diluted share (EPS) in fiscal year 2026. This represents an increase of 7.4% from the prior year.
Cash & Balance Sheet
Science Applications Intl Corp generated $577.0M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 26.0% from the prior year.
Science Applications Intl Corp held $182.0M in cash against $2.5B in long-term debt as of fiscal year 2026.
Science Applications Intl Corp paid $0.37 per share in dividends in fiscal year 2026. That is unchanged from the prior year.
Margins & Returns
Science Applications Intl Corp's gross margin was 12.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 0.1 percentage points from the prior year.
Science Applications Intl Corp's operating margin was 7.2% in fiscal year 2026, reflecting core business profitability. This is down 0.4 percentage points from the prior year.
Science Applications Intl Corp's net profit margin was 4.9% in fiscal year 2026, showing the share of revenue converted to profit. This is up 0.1 percentage points from the prior year.
Science Applications Intl Corp's ROE was 23.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the prior year.
Capital Allocation
Science Applications Intl Corp invested $13.0M in research and development in fiscal year 2026. This represents an increase of 8.3% from the prior year.
Science Applications Intl Corp spent $445.0M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 20.3% from the prior year.
Science Applications Intl Corp invested $32.0M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 11.1% from the prior year.
SAIC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.3B-2.9% | $7.5B+0.5% | $7.4B-3.4% | $7.7B+4.2% | $7.4B+4.8% | $7.1B+10.6% | $6.4B+36.9% | $4.7B+4.6% | $4.5B+0.3% | $4.4B+2.9% | $4.3B+11.1% | $3.9B-5.7% | $4.1B-13.8% | $4.8B+1.0% | $4.7B |
| Cost of Revenue | $6.4B-3.0% | $6.6B+0.2% | $6.6B-3.6% | $6.8B+4.3% | $6.5B+4.3% | $6.3B+10.4% | $5.7B+35.2% | $4.2B+3.8% | $4.0B+1.0% | $4.0B+2.5% | $3.9B+10.0% | $3.5B-6.3% | $3.8B-13.4% | $4.4B+1.5% | $4.3B |
| Gross Profit | $872.0M-2.2% | $892.0M+2.3% | $872.0M-1.8% | $888.0M+3.4% | $859.0M+8.5% | $792.0M+12.2% | $706.0M+52.2% | $464.0M+12.9% | $411.0M-6.4% | $439.0M+6.8% | $411.0M+22.7% | $335.0M+0.6% | $333.0M-18.4% | $408.0M-4.2% | $426.0M |
| R&D Expenses | $13.0M+8.3% | $12.0M+200.0% | $4.0M+300.0% | $1.0M-75.0% | $4.0M-33.3% | $6.0M-14.3% | $7.0M+40.0% | $5.0M+25.0% | $4.0M0.0% | $4.0M0.0% | $4.0M-20.0% | $5.0M+25.0% | $4.0M+33.3% | $3.0M-62.5% | $8.0M |
| SG&A Expenses | $350.0M+3.2% | $339.0M-9.1% | $373.0M-0.3% | $374.0M+8.7% | $344.0M-2.3% | $352.0M+22.2% | $288.0M+82.3% | $158.0M+1.9% | $155.0M-6.6% | $166.0M-9.8% | $184.0M+93.7% | $95.0M+3.3% | $92.0M-7.1% | $99.0M-22.0% | $127.0M |
| Operating Income | $521.0M-7.5% | $563.0M-24.0% | $741.0M+47.9% | $501.0M+8.4% | $462.0M+18.5% | $390.0M+5.4% | $370.0M+68.2% | $220.0M-14.1% | $256.0M-2.7% | $263.0M+15.9% | $227.0M-5.4% | $240.0M+31.1% | $183.0M-34.9% | $281.0M-6.0% | $299.0M |
| Interest Expense | $128.0M+1.6% | $126.0M+5.0% | $120.0M0.0% | $120.0M+14.3% | $105.0M-13.9% | $122.0M+35.6% | $90.0M+69.8% | $53.0M+20.5% | $44.0M-15.4% | $52.0M+18.2% | $44.0M+158.8% | $17.0M+142.9% | $7.0M | N/A | N/A |
| Income Tax | $29.0M-56.1% | $66.0M-53.8% | $143.0M+98.6% | $72.0M-8.9% | $79.0M+31.7% | $60.0M+5.3% | $57.0M+72.7% | $33.0M-5.7% | $35.0M-49.3% | $69.0M+4.5% | $66.0M-19.5% | $82.0M+30.2% | $63.0M-36.4% | $99.0M-14.7% | $116.0M |
| Net Income | $358.0M-1.1% | $362.0M-24.1% | $477.0M+57.4% | $303.0M+8.6% | $279.0M+33.5% | $209.0M-7.5% | $226.0M+65.0% | $137.0M-23.5% | $179.0M+25.2% | $143.0M+22.2% | $117.0M-17.0% | $141.0M+24.8% | $113.0M-37.9% | $182.0M0.0% | $182.0M |
| EPS (Diluted) | $7.70+7.4% | $7.17-19.3% | $8.88+65.1% | $5.38+12.8% | $4.77+34.0% | $3.56-7.0% | $3.83+23.2% | $3.11-22.6% | $4.02+28.8% | $3.12+26.3% | $2.47-15.1% | $2.91+28.2% | $2.27-38.0% | $3.660.0% | $3.66 |
SAIC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.4B+2.1% | $5.2B-1.3% | $5.3B-4.1% | $5.5B-3.5% | $5.7B+0.4% | $5.7B+21.5% | $4.7B+3.2% | $4.6B+120.1% | $2.1B+1.5% | $2.0B-3.8% | $2.1B+52.8% | $1.4B-4.0% | $1.4B+16.2% | $1.2B | N/A |
| Current Assets | $1.2B+2.2% | $1.2B+2.0% | $1.1B-5.5% | $1.2B-5.2% | $1.3B-2.0% | $1.3B-9.9% | $1.4B-0.2% | $1.4B+50.8% | $950.0M+5.4% | $901.0M-5.4% | $952.0M+1.1% | $942.0M-5.2% | $994.0M+22.9% | $809.0M | N/A |
| Cash & Equivalents | $182.0M+225.0% | $56.0M-40.4% | $94.0M-13.8% | $109.0M+2.8% | $106.0M-38.0% | $171.0M-9.0% | $188.0M-20.7% | $237.0M+64.6% | $144.0M-31.4% | $210.0M+7.7% | $195.0M-35.2% | $301.0M+18.5% | $254.0M+25300.0% | $1.0M0.0% | $1.0M |
| Inventory | N/A | N/A | $3.0M-95.8% | $71.0M+10.9% | $64.0M-17.9% | $78.0M-7.1% | $84.0M+13.5% | $74.0M+8.8% | $68.0M-4.2% | $71.0M+4.4% | $68.0M+1.5% | $67.0M+13.6% | $59.0M-37.2% | $94.0M | N/A |
| Accounts Receivable | $853.0M-14.7% | $1.0B+9.4% | $914.0M-2.4% | $936.0M-7.8% | $1.0B+5.5% | $962.0M-12.5% | $1.1B+4.7% | $1.1B+55.8% | $674.0M+25.0% | $539.0M-15.1% | $635.0M+16.7% | $544.0M-12.4% | $621.0M-10.1% | $691.0M | N/A |
| Goodwill | $2.9B+3.3% | $2.9B0.0% | $2.9B-2.1% | $2.9B-0.1% | $2.9B+4.5% | $2.8B+30.3% | $2.1B+0.9% | $2.1B+145.7% | $863.0M0.0% | $863.0M+0.3% | $860.0M+126.9% | $379.0M0.0% | $379.0M0.0% | $379.0M | N/A |
| Total Liabilities | $3.9B+5.0% | $3.7B+4.0% | $3.5B-8.3% | $3.8B-6.7% | $4.1B-1.3% | $4.2B+26.9% | $3.3B+7.0% | $3.1B+76.3% | $1.7B+3.1% | $1.7B-2.8% | $1.7B+66.9% | $1.0B-2.4% | $1.1B+64.9% | $649.0M | N/A |
| Current Liabilities | $982.0M-29.7% | $1.4B+20.6% | $1.2B+2.8% | $1.1B-16.7% | $1.4B+6.0% | $1.3B+13.0% | $1.1B+25.8% | $897.0M+29.1% | $695.0M+11.6% | $623.0M-9.4% | $688.0M+24.6% | $552.0M-2.1% | $564.0M-11.6% | $638.0M | N/A |
| Long-Term Debt | $2.5B+29.4% | $1.9B-5.7% | $2.0B-13.7% | $2.3B-1.1% | $2.4B-3.1% | $2.4B+32.2% | $1.9B-10.4% | $2.1B+110.1% | $983.0M-3.8% | $1.0B+0.9% | $1.0B+123.1% | $454.0M-7.2% | $489.0M+48800.0% | $1.0M0.0% | $1.0M |
| Total Equity | $1.5B-4.9% | $1.6B-11.7% | $1.8B+5.4% | $1.7B+4.6% | $1.6B+5.0% | $1.5B+8.8% | $1.4B-4.6% | $1.5B+354.1% | $327.0M-6.3% | $349.0M-8.2% | $380.0M+10.1% | $345.0M-8.5% | $377.0M-36.7% | $596.0M-9.1% | $656.0M |
| Retained Earnings | $1.5B-4.7% | $1.6B+9.3% | $1.4B+38.4% | $1.0B+26.5% | $818.0M+30.5% | $627.0M+23.9% | $506.0M+37.9% | $367.0M+13.6% | $323.0M+24.2% | $260.0M+49.4% | $174.0M+50.0% | $116.0M+286.7% | $30.0M | N/A | N/A |
SAIC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $609.0M+23.3% | $494.0M+24.7% | $396.0M-25.6% | $532.0M+2.7% | $518.0M-31.4% | $755.0M+64.8% | $458.0M+148.9% | $184.0M-15.2% | $217.0M-20.5% | $273.0M+20.8% | $226.0M-18.4% | $277.0M+51.4% | $183.0M-34.6% | $280.0M-7.6% | $303.0M |
| Capital Expenditures | $32.0M-11.1% | $36.0M+33.3% | $27.0M+8.0% | $25.0M-30.6% | $36.0M-21.7% | $46.0M+119.0% | $21.0M-25.0% | $28.0M+27.3% | $22.0M+46.7% | $15.0M-25.0% | $20.0M-9.1% | $22.0M+37.5% | $16.0M+128.6% | $7.0M+16.7% | $6.0M |
| Free Cash Flow | $577.0M+26.0% | $458.0M+24.1% | $369.0M-27.2% | $507.0M+5.2% | $482.0M-32.0% | $709.0M+62.2% | $437.0M+180.1% | $156.0M-20.0% | $195.0M-24.4% | $258.0M+25.2% | $206.0M-19.2% | $255.0M+52.7% | $167.0M-38.8% | $273.0M-8.1% | $297.0M |
| Investing Cash Flow | -$248.0M-608.6% | -$35.0M-111.1% | $314.0M+972.2% | -$36.0M+87.7% | -$292.0M+76.3% | -$1.2B-2519.1% | -$47.0M+95.4% | -$1.0B-4572.7% | -$22.0M-29.4% | -$17.0M+97.8% | -$784.0M | N/A | N/A | N/A | N/A |
| Financing Cash Flow | -$235.0M+52.8% | -$498.0M+31.3% | -$725.0M-47.1% | -$493.0M-63.8% | -$301.0M-164.9% | $464.0M+202.0% | -$455.0M-148.5% | $938.0M+459.4% | -$261.0M-5.7% | -$247.0M-153.0% | $466.0M | N/A | N/A | N/A | N/A |
| Dividends Paid | $70.0M-6.7% | $75.0M-5.1% | $79.0M-4.8% | $83.0M-3.5% | $86.0M-1.1% | $87.0M0.0% | $87.0M+64.2% | $53.0M-1.9% | $54.0M0.0% | $54.0M-1.8% | $55.0M+5.8% | $52.0M-82.4% | $295.0M | N/A | N/A |
| Share Buybacks | $445.0M-20.3% | $558.0M+46.1% | $382.0M+43.1% | $267.0M+18.1% | $226.0M+564.7% | $34.0M-82.7% | $197.0M+185.5% | $69.0M-62.9% | $186.0M+3.3% | $180.0M+160.9% | $69.0M-53.7% | $149.0M+1046.2% | $13.0M | N/A | N/A |
SAIC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.0%+0.1pp | 11.9%+0.2pp | 11.7%+0.2pp | 11.5%-0.1pp | 11.6%+0.4pp | 11.2%+0.1pp | 11.1%+1.1pp | 10.0%+0.7pp | 9.2%-0.7pp | 9.9%+0.4pp | 9.5%+0.9pp | 8.6%+0.5pp | 8.1%-0.5pp | 8.5%-0.5pp | 9.0% |
| Operating Margin | 7.2%-0.4pp | 7.5%-2.4pp | 10.0%+3.5pp | 6.5%+0.3pp | 6.3%+0.7pp | 5.5%-0.3pp | 5.8%+1.1pp | 4.7%-1.0pp | 5.8%-0.2pp | 5.9%+0.7pp | 5.3%-0.9pp | 6.2%+1.7pp | 4.4%-1.4pp | 5.9%-0.4pp | 6.3% |
| Net Margin | 4.9%+0.1pp | 4.8%-1.6pp | 6.4%+2.5pp | 3.9%+0.2pp | 3.8%+0.8pp | 3.0%-0.6pp | 3.5%+0.6pp | 2.9%-1.1pp | 4.0%+0.8pp | 3.2%+0.5pp | 2.7%-0.9pp | 3.6%+0.9pp | 2.7%-1.1pp | 3.8%0.0pp | 3.9% |
| Return on Equity | 23.9%+0.9pp | 22.9%-3.8pp | 26.7%+8.8pp | 17.9%+0.7pp | 17.2%+3.7pp | 13.6%-2.4pp | 16.0%+6.7pp | 9.2%-45.5pp | 54.7%+13.8pp | 41.0%+10.2pp | 30.8%-10.1pp | 40.9%+10.9pp | 30.0%-0.6pp | 30.5%+2.8pp | 27.7% |
| Return on Assets | 6.7%-0.2pp | 6.9%-2.1pp | 9.0%+3.5pp | 5.5%+0.6pp | 4.9%+1.2pp | 3.6%-1.2pp | 4.8%+1.8pp | 3.0%-5.6pp | 8.6%+1.6pp | 7.0%+1.5pp | 5.5%-4.6pp | 10.2%+2.3pp | 7.8%-6.8pp | 14.6% | N/A |
| Current Ratio | 1.20+0.4x | 0.83-0.2x | 0.98-0.1x | 1.06+0.1x | 0.93-0.1x | 1.01-0.3x | 1.27-0.3x | 1.60+0.2x | 1.37-0.1x | 1.45+0.1x | 1.38-0.3x | 1.71-0.1x | 1.76+0.5x | 1.27 | N/A |
| Debt-to-Equity | 1.65+0.4x | 1.21+0.1x | 1.13-0.3x | 1.38-0.1x | 1.46-0.1x | 1.59+0.3x | 1.31-0.1x | 1.39-1.6x | 3.01+0.1x | 2.93+0.3x | 2.67+1.3x | 1.320.0x | 1.30+1.3x | 0.000.0x | 0.00 |
| FCF Margin | 8.0%+1.8pp | 6.1%+1.2pp | 5.0%-1.6pp | 6.6%+0.1pp | 6.5%-3.5pp | 10.1%+3.2pp | 6.9%+3.5pp | 3.4%-1.0pp | 4.4%-1.4pp | 5.8%+1.0pp | 4.8%-1.8pp | 6.6%+2.5pp | 4.0%-1.7pp | 5.7%-0.6pp | 6.3% |
Similar Companies
Where Science Applications Intl Corp Ranks
Frequently Asked Questions
What is Science Applications Intl Corp's annual revenue?
Science Applications Intl Corp (SAIC) reported $7.3B in total revenue for fiscal year 2026. This represents a -2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Science Applications Intl Corp's revenue growing?
Science Applications Intl Corp (SAIC) revenue declined by 2.9% year-over-year, from $7.5B to $7.3B in fiscal year 2026.
Is Science Applications Intl Corp profitable?
Yes, Science Applications Intl Corp (SAIC) reported a net income of $358.0M in fiscal year 2026, with a net profit margin of 4.9%.
What is Science Applications Intl Corp's EBITDA?
Science Applications Intl Corp (SAIC) had EBITDA of $551.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Science Applications Intl Corp have?
As of fiscal year 2026, Science Applications Intl Corp (SAIC) had $182.0M in cash and equivalents against $2.5B in long-term debt.
What is Science Applications Intl Corp's gross margin?
Science Applications Intl Corp (SAIC) had a gross margin of 12.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Science Applications Intl Corp's operating margin?
Science Applications Intl Corp (SAIC) had an operating margin of 7.2% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Science Applications Intl Corp's net profit margin?
Science Applications Intl Corp (SAIC) had a net profit margin of 4.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does Science Applications Intl Corp pay dividends?
Yes, Science Applications Intl Corp (SAIC) paid $0.37 per share in dividends during fiscal year 2026.
What is Science Applications Intl Corp's return on equity (ROE)?
Science Applications Intl Corp (SAIC) has a return on equity of 23.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Science Applications Intl Corp's free cash flow?
Science Applications Intl Corp (SAIC) generated $577.0M in free cash flow during fiscal year 2026. This represents a 26.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Science Applications Intl Corp's operating cash flow?
Science Applications Intl Corp (SAIC) generated $609.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Science Applications Intl Corp's total assets?
Science Applications Intl Corp (SAIC) had $5.4B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Science Applications Intl Corp's capital expenditures?
Science Applications Intl Corp (SAIC) invested $32.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Science Applications Intl Corp spend on research and development?
Science Applications Intl Corp (SAIC) invested $13.0M in research and development during fiscal year 2026.
What is Science Applications Intl Corp's current ratio?
Science Applications Intl Corp (SAIC) had a current ratio of 1.20 as of fiscal year 2026, which is considered adequate.
What is Science Applications Intl Corp's debt-to-equity ratio?
Science Applications Intl Corp (SAIC) had a debt-to-equity ratio of 1.65 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Science Applications Intl Corp's return on assets (ROA)?
Science Applications Intl Corp (SAIC) had a return on assets of 6.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Science Applications Intl Corp's Altman Z-Score?
Science Applications Intl Corp (SAIC) has an Altman Z-Score of 2.95, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Science Applications Intl Corp's Piotroski F-Score?
Science Applications Intl Corp (SAIC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Science Applications Intl Corp's earnings high quality?
Science Applications Intl Corp (SAIC) has an earnings quality ratio of 1.70x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Science Applications Intl Corp cover its interest payments?
Science Applications Intl Corp (SAIC) has an interest coverage ratio of 4.07x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Science Applications Intl Corp?
Science Applications Intl Corp (SAIC) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.